Clinical Trial Update: Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and tolerability of intravenous ETX2514 with sulbactam in adults with varying renal function and matched heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection

Drugs mentioned

• ETX2514 (ETX2514)
• Sulbactam (sulbactam)

Snippet

Sponsor: Entasis Therapeutics | Conditions: Acinetobacter Baumannii Infection | Phase 1 | Status: COMPLETED